Gradient Investments’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-945
Closed -$5.67K 1568
2023
Q4
$5.67K Hold
945
﹤0.01% 965
2023
Q3
$6.09K Hold
945
﹤0.01% 906
2023
Q2
$4.11K Hold
945
﹤0.01% 992
2023
Q1
$3.39K Hold
945
﹤0.01% 1026
2022
Q4
$3.52K Hold
945
﹤0.01% 996
2022
Q3
$4K Hold
945
﹤0.01% 1002
2022
Q2
$4K Hold
945
﹤0.01% 936
2022
Q1
$4K Sell
945
-26
-3% -$144 ﹤0.01% 931
2021
Q4
$6K Hold
971
﹤0.01% 903
2021
Q3
$7K Hold
971
﹤0.01% 834
2021
Q2
$7K Hold
971
﹤0.01% 824
2021
Q1
$9K Hold
971
﹤0.01% 785
2020
Q4
$12K Hold
971
﹤0.01% 664
2020
Q3
$12K Buy
+971
New +$13.1K ﹤0.01% 668
2020
Q2
Sell
-971
Closed -$10K 1129
2020
Q1
$10K Buy
+971
New +$13.3K ﹤0.01% 649

Other funds holding LFVN

Gradient Investments's LFVN Position: Q1 2024 in Review

Gradient Investments sold out of LifeVantage (LFVN) in Q1 2024, closing a stake of 945 shares — an estimated $5.67K sold.

Gradient Investments first reported a position in LFVN in Q1 2020 and held it in 15 quarters. The position peaked at $12K in Q4 2020. 52 funds tracked by Wall St. Rank hold LFVN as of Q1 2024.

  • Gradient Investments reported no remaining LifeVantage position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 945 LifeVantage shares in Q1 2024, an estimated $5.67K.
  • Gradient Investments first reported a position in LifeVantage in Q1 2020 and held it in 15 quarters.
  • Gradient Investments's LifeVantage position peaked at $12K in Q4 2020.
  • 52 funds tracked by Wall St. Rank held LifeVantage as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.